H.R. 919 House Taxation
Chronic Disease Flexible Coverage Act
STAGE 4 OF 8 — HOUSE FLOOR
Currently in the House. Last action: received in the senate and read twice and referred to the committee on finance on Mar 5, 2025.
- House Introduced in House Feb 4, 2025
- House Referred to the House Committee on Ways and Means. Feb 4, 2025
- House Mr. Smith (MO) moved to suspend the rules and pass the bill. Mar 4, 2025
- House Considered under suspension of the rules. (consideration: CR H964-966) Mar 4, 2025
- House DEBATE - The House proceeded with forty minutes of debate on H.R. 919. Mar 4, 2025
- House Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964) Mar 4, 2025
- House On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964) Mar 4, 2025
- House Motion to reconsider laid on the table Agreed to without objection. Mar 4, 2025
- Senate Received in the Senate and Read twice and referred to the Committee on Finance. Mar 5, 2025
Cosponsors
2
Subjects
Health care costs and insuranceHealth care coverage and accessHealth promotion and preventive careIncome tax deductions
Committees
- Finance Committee
- [Referred To, Mar 5, 2025]
- Ways and Means Committee
- [Referred To, Feb 4, 2025]
Summary
Chronic Disease Flexible Coverage ActThis bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold. The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to includeangiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;anti-resorptive therapy for individuals with osteoporosis or osteopenia;beta-blockers for individuals with congestive heart failure or coronary artery disease;blood pressure monitors for individuals with hypertension;inhaled corticosteroids and peak flow meters for individuals with asthma;insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;international normalized ratio testing for individuals with liver disease or bleeding disorders;low-density lipoprotein testing for individuals with heart disease;statins for individuals with heart disease or diabetes; andselective serotonin reuptake inhibitors for individuals with depression. The bill provides statutory authority for the IRS's guidance.
[Summary as of: Introduced in House]
Comments · 0
Please log in to post a comment.
Loading comments...